Køge Hospital
Køge, State..., 4600, Denmark
NCT Number: NCT01988545
to investigate the effect of the human incretin hormone GLP-1 on mesenteric blood flow and cardiac parameters
Looking for future studies?
Notify Me20 year–80 year
All sexes
Interventional
Not applicable
Køge, State..., 4600, Denmark
to investigate the effect of the human incretin hormone GLP-1 on mesenteric blood flow and cardiac parameters, in healthy subjects, 4 arms, task force monitor
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: native GLP-1
Time frame: with in 120 minutes
blood flow change measured by ultra sound
Time frame: with in 120 minutes
measure of cardiac change with task force monitor
Zealand University Hospital
Other
GLP-1's Influence on Intestinal Blood Flow
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02285452
Healthy
Filderstadt, Baden-Wurttemberg, Germany
View Trial DetailsNCT07347470
Healthy
Ramat Gan, Israel
View Trial DetailsNCT03539666
Healthy
Brookings, South Dakota, United States
View Trial DetailsNCT07693218
Healthy
Groningen, Netherlands
View Trial Details